Trials / Completed
CompletedNCT00308191
A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPD
A 6-Week Double-Blind, Parallel-Group, Active-Controlled Trial to Compare the Efficacy and Safety of Concomitant Treatment of Formoterol Fumarate Inhalation Solution 20 Mcg Twice Daily and Tiotropium 18 Mcg Once Daily to Tiotropium 18 Mcg Once Daily Alone in the Treatment of Patients With Chronic Obstructive Pulmonary Disease
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 128 (planned)
- Sponsor
- Dey · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of the concomitant treatment of formoterol fumarate with tiotropium bromide compared to treatment with tiotropium bromide alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Formoterol Fumarate | |
| DRUG | Tiotropium Bromide |
Timeline
- Start date
- 2006-04-01
- Primary completion
- 2006-05-01
- Completion
- 2006-12-01
- First posted
- 2006-03-29
- Last updated
- 2008-03-07
Locations
17 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00308191. Inclusion in this directory is not an endorsement.